From FDA reports: Cabergoline and Intermenstrual bleeding

This is a study of Intermenstrual bleeding (Vaginal bleeding between periods) among people who take Cabergoline. The study analyzes: the time on Cabergoline when people have Intermenstrual bleeding, age of these people, the severity of Intermenstrual bleeding, how they recovered, and common conditions and drugs used besides Cabergoline. In total 2,095 Cabergoline users are studied. The study is created by eHealthMe based on reports from FDA and is updated regularly.

Do you have a question? Healthcare is personal: one drug can work differently between women and men, or for people of different ages. How do you find patients like you to answer your question, and ensure only patients like you can answer it? Our Personalized Q&A can help. Start now

Cabergoline

Cabergoline has active ingredients of cabergoline. It is used in prolactinoma, pituitary tumor, hyperprolactinaemia, pituitary tumour, pituitary tumour benign. Commonly reported side effects of Cabergoline include mitral valve incompetence, pleural effusion, aortic valve incompetence, cardiac failure, hallucinations.

Intermenstrual bleeding

Intermenstrual bleeding has been reported by people with birth control, menorrhagia, menstruation irregular, endometriosis, oral contraception.

On Jun, 3, 2013: 2,095 people reported to have side effects when taking Cabergoline. Among them, 2 people (0.10%) have Intermenstrual Bleeding.

Time on Cabergoline when people have Intermenstrual bleeding * :

Age of people who have Intermenstrual bleeding when taking Cabergoline * :

Severity of Intermenstrual bleeding when taking Cabergoline ** :

How people recovered from Intermenstrual bleeding ** :

Top conditions involved for these people * :

1. Neoplasm (1 people, 50.00%)
2. Prolactin-producing pituitary tumour (1 people, 50.00%)

Login or sign up (it's free) to view more results.

Top co-used drugs for these people * :

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

(If the study does not answer your question, use Personalized Q&A)

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: check whether intermenstrual bleeding is from a drug or a condition

You can also:

• ask a question from patients like you
• get notified of updates of this study
• post a comment
• get our mobile app: never miss a symptom, compare it with patients like me in real time, and discuss it with doctors later

On eHealthMe, Cabergoline (cabergoline) is often used for prolactinoma. Find out below the conditions Cabergoline is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.

What is Cabergoline used for and how effective is it:

• Cabergoline is used in:
  • Prolactinoma
  • Pituitary tumor
  • Hyperprolactinaemia
  • Pituitary tumour
  • Pituitary tumour benign

Other drugs that are used to treat the same conditions:

• Cabergoline alternatives:
  • Prolactinoma (3 drugs)
  • Pituitary tumor (3 drugs)
  • Hyperprolactinaemia (3 drugs)
  • Pituitary tumour (1 drug)
  • Pituitary tumour benign (3 drugs)

Browse Cabergoline side effects from A to Z:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Browse Cabergoline drug interactions with drugs from A to Z:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Drugs in real world that are associated with:

• Intermenstrual Bleeding (Vaginal bleeding between periods)

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent drug studies on eHealthMe: